Artificial DNA kills cancer cells
26 January, 2023Researchers developed a chemically synthesised, hairpin-shaped DNA strand that can activate a natural immune response to target and kill specific cancerous cells.
Light therapy eliminates antibiotic-resistant superbugs
23 January, 2023The photodynamic technology harnesses the energy of light to generate highly reactive oxygen molecules that eradicate microbial cells and kill deadly bacteria.
Queensland invests in global mRNA vaccine hub
08 December, 2022Sanofi has partnered with the Queensland Government, The University of Queensland and Griffith University to inject $280 million into a next-generation mRNA vaccine research hub.
With funding dwindling, how can biotech companies maintain momentum?
06 December, 2022 by Glenn Bilawsky, CEOPartnering with biopharmaceutical outsourcing companies provides an opportunity for drug and diagnostic developers to better leverage their assets.
Gene therapy trial for type 1 diabetes to proceed
30 November, 2022The trial is set to be the first time that genetically engineered pancreatic islet cells will be transplanted into humans to treat type 1 diabetes.
$352m plasma therapeutics plant coming to Qld
29 November, 2022Aegros, which is currently based in Sydney, will establish its global headquarters and a one-million-litre plasma fractionation facility in Springfield's BioPark Australia precinct.
A second chance for UQ's molecular clamp vaccine platform
28 November, 2022UQ is set to take a second-generation 'molecular clamp' vaccine to a proof-of-concept human trial, after CEPI announced funding to support the technology.
Syringe to improve sperm selection for infertile couples
25 November, 2022Bioengineering researchers have developed a syringe that uses a 3D filter to detect and isolate viable sperm in less than 15 minutes.
Urine could play a key part in biotech systems
22 November, 2022A common chemical found in urine can be used to kick-start large-scale production of proteins such as hormones and antibodies used by biotech companies.
Bionic pancreas simplifies type 1 diabetes management
14 November, 2022Compared to other available artificial pancreas technologies, the bionic pancreas is designed to require less user input and provides more automation.
DNA nanotransporters optimise drug delivery
09 November, 2022Researchers have designed a new class of drug transporters made of DNA that are 20,000 times smaller than a human hair and could improve how diseases are treated.
Drug found to reduce sleep apnoea severity
09 November, 2022A drug previously used to treat depression has been found to reduce obstructive sleep apnoea severity.
Breakthrough for drug delivery through blood–brain barrier
28 October, 2022In a major advance for the treatment of Alzheimer's, Australian scientists have successfully delivered drugs through patient cell models of the human blood–brain barrier.
Five-year project to develop next-gen TB vaccines
10 October, 2022The Centenary Institute and the University of Sydney have been awarded a $19m contract to develop the next generation of tuberculosis vaccines.
Brain cancer drug candidate fast-tracked in clinical trials
10 October, 2022An experimental drug for advanced solid tumours, including aggressive glioblastoma, has passed the first phase of clinical trials with flying colours.
